Lv1
68 积分 2024-11-01 加入
Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective study
3个月前
已完结
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial
4个月前
已完结
Delayed Remission With Advanced Therapies Is Not Associated With Worse One-Year Outcomes In Inflammatory Bowel Disease
5个月前
已完结
Epidermal Growth Factor for Ulcerative Colitis
8个月前
已完结
Oral alginate microspheres for the efficient site-specific delivery of epidermal growth factor attenuated murine ulcerative colitis via repairing the mucosal barrier
8个月前
已完结
The evolving role of JAK inhibitors in the treatment of inflammatory bowel disease
8个月前
已完结
Cardiovascular safety, cancer and Jak-inhibitors: Differences to be highlighted
8个月前
已完结
Unmet Therapeutic Needs: Focus on Intestinal Fibrosis Surgical Approach: Resection, Strictureplasty and Others
8个月前
已完结
皖公网安备34019202002308
